title: High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?
authors.affiliation: Department of Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland. markus.joerger@gmail.com
authors.forename: Markus
authors.initials: M
authors.lastname: Joerger
authors.forename: A D R
authors.initials: AD
authors.lastname: Huitema
authors.forename: G
authors.initials: G
authors.lastname: Illerhaus
authors.forename: A J M
authors.initials: AJ
authors.lastname: Ferreri
mesh_terms: D016543:Central Nervous System Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000493:pharmacokinetics*
chemical_list: D008727:Methotrexate